Analysts think HSDT stock price could increase by 482%
Aug 01, 2024, 6:26 AM
8.99%
What does HSDT do
Helius Medical Technologies Inc, based in Newtown, Pennsylvania, specializes in non-implantable neurotech devices like PoNS, which treats neurologic diseases by stimulating the tongue to improve gait and balance deficits. The company, which went public in 2014, focuses on developing technologies to alleviate symptoms of neurological disorders.
3 analysts think HSDT stock price will increase by 482.03%. The current median analyst target is $4.08 compared to a current stock price of $0.70. The lowest analysts target is $4.04 and the highest analyst target is $4.20.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
